fruquintinib
Phase 1Completed 1 views this week 0 watching💤 Quiet
Interest: 23/100
23
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Food Effect of Fruquintinib in Health Subjects
Conditions
Food Effect of Fruquintinib in Health Subjects
Trial Timeline
Jun 1, 2012 → Dec 1, 2012
NCT ID
NCT01955304About fruquintinib
fruquintinib is a phase 1 stage product being developed by HUTCHMED for Food Effect of Fruquintinib in Health Subjects. The current trial status is completed. This product is registered under clinical trial identifier NCT01955304. Target conditions include Food Effect of Fruquintinib in Health Subjects.
What happened to similar drugs?
2 of 3 similar drugs in Food Effect of Fruquintinib in Health Subjects were approved
Approved (2) Terminated (1) Active (0)
Hype Score Breakdown
Clinical
6
Activity
8
Company
9
Novelty
0
Community
0
Clinical Trials (7)
| NCT ID | Phase | Status |
|---|---|---|
| NCT05216354 | Phase 1 | Completed |
| NCT05216367 | Phase 1 | Completed |
| NCT03684967 | Phase 2 | Withdrawn |
| NCT02689752 | Phase 1 | Completed |
| NCT01975077 | Phase 1/2 | Completed |
| NCT01955304 | Phase 1 | Completed |
| NCT01645215 | Phase 1 | Completed |
Competing Products
17 competing products in Food Effect of Fruquintinib in Health Subjects